Pazobrite 400mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Pazopanib (400mg)
Overview Pazobrite 400mg Tablet
Vorinostat 400mg tablets, a protein kinase inhibitor, are indicated for kidney cancer and soft-tissue sarcoma treatment. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include diarrhea and hypertension. Regular blood pressure monitoring may be recommended. Manage diarrhea with increased fluid intake or consult your physician if severe. This medication can decrease blood cell counts, increasing infection risk; report fever, flu-like symptoms, or shortness of breath immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial medications. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is crucial throughout treatment.
Primary Ingredients of Pazobrite 400mg Tablet
No information provided. A text is needed to rephrase.
Uses of Pazobrite 400mg Tablet
Renal cell carcinoma or soft tissue sarcoma
Major Benefits of Pazobrite 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 400mg Pazobrite tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Pazobrite 400mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazobrite 400mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 400mg Pazobrite tablet whole; avoid chewing, crushing, or fracturing it. Consumption should be on an empty stomach.
How Pazobrite 400mg Tablet works:
Pazobrite 400mg tablets are an anti-neoplastic agent. Their mechanism of action involves targeting and blocking tyrosine kinase enzyme receptors, thus curbing cancerous cell growth. The medication also impedes angiogenesis, the formation of new blood vessels within the tumor, further hindering its expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazobrite 400mg tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Pazobrite 400mg tablets during pregnancy poses a confirmed risk to the unborn child. Therefore, its use is not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the use of 400mg Pazobrite tablets are incompatible. Evidence indicates a potential risk of infant toxicity from this medication.
DrivingUNSAFE
Taking a 400mg Pazobrite tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Pazobrite 400mg tablets can be administered to patients with kidney disease without modification of the dosage.
LiverCAUTION
For individuals with liver impairment, Pazobrite 400mg tablets require careful administration. Dosage modification may be necessary. A physician's consultation is recommended. Pazobrite 400mg tablets are contraindicated for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Pazobrite 400mg Tablet :
NA
Facts to Know About Pazobrite 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently